AMRX

NASDAQStock

Amneal Pharmaceuticals, Inc.

$12.06-0.65 (-5.07%)

52-Week Range

$6.97

$15.19

Key Stats

Market Cap

3.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.30

Volume

2.1M

Avg Volume

2.3M

Performance

-17.59%

-2.77%

+23.75%

YTD

-4.30%

+37.83%

+747.20%

+73.57%

Price Chart

ETF Exposure

AMRX is held by 107 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	54	$720	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	41	$545	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	18	$242	$9.5M	0.12%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	375	$5K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	1,147	$15K	$1.69B	0.20%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	13	$171	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	42	$565	$81.5M	0.10%

PreviousPage 3 of 3

About AMRX ETF Exposure

Amneal Pharmaceuticals, Inc. (AMRX) is held by 107 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.8B, AMRX is a widely held institutional stock. The stock currently trades at $12.06. Investors can gain exposure to AMRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AMRX, sorted by portfolio weight.